Renaissance Technologies’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $609M | Buy |
|
|||||
|
2025
Q1 | $650M | Buy |
|
|||||
|
2024
Q4 | $737M | Sell |
|
|||||
|
2024
Q3 | $772M | Sell |
|
|||||
|
2024
Q2 | $693M | Buy |
|
|||||
|
2024
Q1 | $494M | Sell |
|
|||||
|
2023
Q4 | $477M | Sell |
|
|||||
|
2023
Q3 | $508M | Buy |
|
|||||
|
2023
Q2 | $483M | Sell |
|
|||||
|
2023
Q1 | $499M | Sell |
|
|||||
|
2022
Q4 | $652M | Sell |
|
|||||
|
2022
Q3 | $534M | Sell |
|
|||||
|
2022
Q2 | $658M | Buy |
|
|||||
|
2022
Q1 | $496M | Sell |
|
|||||
|
2021
Q4 | $630M | Sell |
|
|||||
|
2021
Q3 | $559M | Sell |
|
|||||
|
2021
Q2 | $558M | Sell |
|
|||||
|
2021
Q1 | $537M | Sell |
|
|||||
|
2020
Q4 | $548M | Sell |
|
|||||
|
2020
Q3 | $375M | Sell |
|
|||||
|
2020
Q2 | $451M | Buy |
|
|||||
|
2020
Q1 | $340M | Buy |
|
|||||
|
2019
Q4 | $312M | Buy |
|
|||||
|
2019
Q3 | $256M | Buy |
|
|||||
|
2019
Q2 | $237M | Buy |
|
|||||
|
2019
Q1 | $263M | Buy |
|
|||||
|
2018
Q4 | $239M | Buy |
|
|||||
|
2018
Q3 | $249M | Buy |
|
|||||
|
2018
Q2 | $176M | Buy |
|
|||||
|
2018
Q1 | $172M | Buy |
|
|||||
|
2017
Q4 | $216M | Buy |
|
|||||
|
2017
Q3 | $149M | Buy |
|
|||||
|
2017
Q2 | $109M | Buy |
|
|||||
|
2017
Q1 | $68.5M | Buy |
|
|||||
|
2016
Q4 | $60.4M | Buy |
|
|||||
|
2016
Q3 | $46.1M | Sell |
|
|||||
|
2016
Q2 | $42.8M | Sell |
|
|||||
|
2016
Q1 | $52.9M | Sell |
|
|||||
|
2015
Q4 | $86.5M | Sell |
|
|||||
|
2015
Q3 | $114M | Buy |
|
|||||
|
2015
Q2 | $141M | Buy |
|
|||||
|
2015
Q1 | $77M | Buy |
|
|||||
|
2014
Q4 | $24M | Buy |
|
|||||
|
2014
Q3 | $306K | Sell |
|
|||||
|
2014
Q2 | $22.3M | Sell |
|
|||||
|
2014
Q1 | $27.1M | Buy |
|
|||||
|
2013
Q4 | $25.4M | Sell |
|
|||||
|
2013
Q3 | $34.8M | Sell |
|
|||||
|
2013
Q2 | $38.9M | Buy |
|